dsp 4 has been researched along with Nervous System Disorders in 2 studies
DSP 4: RN given refers to parent cpd
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zieher, LM | 1 |
| Jaim-Etcheverry, G | 1 |
| Finnegan, KT | 1 |
| Skratt, JJ | 1 |
| Irwin, I | 1 |
| DeLanney, LE | 1 |
| Langston, JW | 1 |
2 other studies available for dsp 4 and Nervous System Disorders
| Article | Year |
|---|---|
Neurotoxicity of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride (DSP 4) on noradrenergic neurons is mimicked by its cyclic aziridinium derivative.
Topics: Amines; Animals; Benzylamines; Brain Chemistry; Desipramine; Female; Injections, Intraventricular; M | 1980 |
Protection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibition of MAO B.
Topics: Allyl Compounds; Animals; Benzylamines; Butylamines; Hippocampus; Kinetics; Male; Mice; Mice, Inbred | 1990 |